Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a pseudogene related to the solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1). Pseudogenes are genomic DNA sequences similar to known genes but are non-functional due to mutations, deletions, or insertions that prevent the synthesis of a functional protein. Unlike canonical solute carrier family 9 transporters, which include functioning sodium/proton antiporters involved in ion homeostasis and have roles in neurological and developmental disorders[9], this pseudogene does not encode an active transporter and lacks any known biological activity, disease relevance, drug interactions, or biomarker utility[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member pseudogene (ENSG00000283659).